Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
University of York researchers launch major study of lymphoma and myeloma

University of York researchers launch major study of lymphoma and myeloma

Coca-Cola sold in California now contains little of cancer-causing chemical 4-methylimidizole

Coca-Cola sold in California now contains little of cancer-causing chemical 4-methylimidizole

Fusion of FGFR and TACC gene leads to glioblastoma

Fusion of FGFR and TACC gene leads to glioblastoma

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

American Society of Hematology announces new grant program for biomedical research

American Society of Hematology announces new grant program for biomedical research

Researchers decipher function of β-catenin in generating blood tissue stem cells

Researchers decipher function of β-catenin in generating blood tissue stem cells

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

Bio-Path initiates enrollment in fourth cohort of Liposomal Grb-2 Phase I trial for blood cancers

CytRx commences aldoxorubicin plus doxorubicin Phase 1b trial in advanced solid tumors

CytRx commences aldoxorubicin plus doxorubicin Phase 1b trial in advanced solid tumors

Cepheid launches new Xpert BCR-ABL Monitor test

Cepheid launches new Xpert BCR-ABL Monitor test

Karyopharm commences two KPT-330 phase 1 studies in cancers

Karyopharm commences two KPT-330 phase 1 studies in cancers

EntreMed commences ENMD-2076 Phase 2 study in triple-negative breast cancer

EntreMed commences ENMD-2076 Phase 2 study in triple-negative breast cancer

Giving patients a new immune system can cure Crohn's disease

Giving patients a new immune system can cure Crohn's disease

Study represents new use of bone marrow transplantation

Study represents new use of bone marrow transplantation

Genetic underpinnings of Wiedemann-Steiner syndrome identified

Genetic underpinnings of Wiedemann-Steiner syndrome identified

Researchers identify several gene mutations responsible for medulloblastoma

Researchers identify several gene mutations responsible for medulloblastoma

Janssen-Cilag receives positive opinion from EMA CHMP for DACOGEN

Janssen-Cilag receives positive opinion from EMA CHMP for DACOGEN

Allergy to deamidated gluten a separate phenotype to wheat allergy

Allergy to deamidated gluten a separate phenotype to wheat allergy

Study helps explain why leukemia occurs more frequently as people age

Study helps explain why leukemia occurs more frequently as people age

Actinium completes Actimab-A Phase I/II study on Acute Myeloid Leukemia

Actinium completes Actimab-A Phase I/II study on Acute Myeloid Leukemia

NCCN Guidelines for Patients: Lung Cancer Screening now available free of charge

NCCN Guidelines for Patients: Lung Cancer Screening now available free of charge

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.